Fundology

ETF · Invesco

0MT7 Invesco STOXX Europe 600 Optimised Health Care UCITS ETF

ISIN IE00B5MJYY16London Stock Exchange: 0MT7Invesco Ltd.

Latest close

LSE

€456.50

on

Ongoing charge
0.20% a year
Fund size
£10.9m

As of , at least 15 min delayed

At a glance

As of 20/11/2026, 0MT7 (Invesco STOXX Europe 600 Optimised Health Care UCITS ETF, ISIN IE00B5MJYY16) closed at €456.50 on the London Stock Exchange. Its ongoing charge is 0.20% a year (about £20 on £10,000). Over the five years to 20/11/2026 its total return was +25.7%, or −1.4% after UK CPIH inflation.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges. Periods to .
1 year to 20/11/2026
+7.0%
+3.2% after inflation
3 years to 20/11/2026
+25.5%
+13.0% after inflation
5 years to 20/11/2026
+25.7%
−1.4% after inflation

£1,000 put in five years ago would have been worth about £1,257 on 20/11/2026 — about £986 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.

Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

Charges compared with similar funds

The ongoing charge is taken from the fund’s value every day, so the returns on this page are already after it. Platform and dealing fees are charged separately.
Ongoing charge
0.20%
a year
On £10,000
£20
a year, roughly
Over five years
£100
of £10,000, before growth
Among 29 healthcare funds, share classes counted once
  • 8 charge less
  • 1 the same
  • 19 charge more

Ongoing charge of Invesco STOXX Europe 600 Optimised Health Care UCITS ETF 0.20% a year. Compared on 21/11/2026, 19 of the 28 other healthcare funds charge more, 1 the same and 8 less (share classes counted once).

As of

A lower charge is not a promise of a higher return: what the fund holds matters more.

As of

Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up

In plain English

Invesco STOXX Europe 600 Optimised Health Care UCITS ETF is an exchange-traded fund (ETF) from Invesco, launched in 2009.

It tracks the STOXX Europe 600 Optimised Health Care Index — large and medium-sized European companies.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Its ongoing charge is 0.2% a year — about £20 a year on every £10,000 invested, taken from the fund's value rather than billed to you.

Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Healthcare: Pharmaceutical, biotech and medical-equipment companies.

Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN

Key facts

Ticker
0MT7
ISIN
IE00B5MJYY16
Also listed as
SC0T (Xetra, euros)
Provider
Invesco
Tracks
STOXX Europe 600 Optimised Health Care Index
Structure
ETF
An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
Income
Accumulating
Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Ongoing charge
0.20% a year · about £20 on £10,000
Fund size
£10.9m
Launched
Domicile
Ireland
UK reporting fund status
Yes — on HMRC’s list of reporting funds (list of )
Reporting fund since . What reporting fund status means
Can usually be held in
ISA and SIPP
Check with your platform: each decides which funds it offers.
Currency hedged
No
Price currency
EUR
Category
Healthcare

Price chart

Closing price
€456.50+10.0% over 1 year · closing price
0MT7 closing price: €415.01 on 28/11/2025, €456.50 on 20/11/2026 (+10.0%); low €404.35, high €472.75.

Over the last year, the closing price went from €415.01 on 28/11/2025 to €456.50 on 20/11/2026 (+10.0%). The lowest close shown was €404.35 on 09/10/2026 and the highest €472.75 on 13/11/2026.

One close a week. Before 23/10/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded.

As of , at least 15 min delayed

Five years of prices, and after inflation

62 weekly closes, from 17/12/2021 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.

Create a free account to see the 5-year price chart and the after-inflation chart

Sign-up takes an email address. There is no card to enter and nothing to pay.

How we work it out:Prices and returnsNAV and price

What it holds

As of , 0MT7 holds 43 positions, according to its published holdings. The largest is AstraZeneca at 10.55% of the fund; the ten largest make up 66.1%.
Holdings
43
on record
Ten largest
66.1%
of the whole fund
Effective number of holdings
17
As concentrated as this many equal-sized holdings (how it is worked out)
Largest holding
10.6%
AstraZeneca

Top 10 holdings

Top holdings of 0MT7: the ten largest, as a percentage of the whole fund, as of 03/11/2026
Rank#HoldingWeight as a percentage of the fund
1AstraZenecaAZN10.55%
2NovartisNOVN10.54%
3RocheRO10.17%
4Novo NordiskNOVO_B7.34%
5SanofiSAN6.60%
6GSKGSK6.46%
7EssilorLuxotticaEL4.22%
8BayerBAYN3.71%
9Lonza GroupLONN3.63%
10Sandoz GroupSDZ2.89%

As of , holdings as published

Where it invests

The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

By sector

  1. Health Care98.4%
  2. Materials1.6%
As published for the fund, as of 03/11/2026.

By country

  1. Switzerland21.8%
  2. United Kingdom21.0%
  3. United States20.3%
  4. Denmark12.1%
  5. Germany9.1%
  6. France5.9%
  7. Belgium5.4%
  8. Netherlands1.6%
  9. Other countries2.8%
As published for the fund, as of 03/11/2026.

See the full portfolio

Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 43 largest and what changed since .

All 43 holdings of 0MT7

All holdings

The fund publishes 43 holdings; the ten largest make up 66.1% of it.

Create a free account to see the full holdings list

Sign-up takes an email address. There is no card to enter and nothing to pay.

Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured

Questions people ask

What is the ongoing charge of 0MT7?

The ongoing charge of 0MT7 is 0.20% a year — about £20 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco STOXX Europe 600 Optimised Health Care UCITS ETF 0.20% a year. Compared on 21/11/2026, 19 of the 28 other healthcare funds charge more, 1 the same and 8 less (share classes counted once).

What does 0MT7 track?

0MT7 tracks the STOXX Europe 600 Optimised Health Care Index — large and medium-sized European companies.

Is 0MT7 accumulating or distributing?

0MT7 is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

What is the ISIN of 0MT7?

The ISIN of 0MT7 is IE00B5MJYY16. An ISIN identifies one exact share class of a fund; 0MT7 is its ticker on the London Stock Exchange. The same share class is also listed as SC0T (Xetra, euros).

What does 0MT7 hold?

As of 03/11/2026, 0MT7 holds 43 positions, according to its published holdings. The largest is AstraZeneca at 10.55% of the fund; the ten largest make up 66.1%. Its ten largest holdings are AstraZeneca (10.55%), Novartis (10.54%), Roche (10.17%), Novo Nordisk (7.34%), Sanofi (6.60%), GSK (6.46%), EssilorLuxottica (4.22%), Bayer (3.71%), Lonza Group (3.63%) and Sandoz Group (2.89%).

How has 0MT7 done after inflation?

Over the five years to 20/11/2026 0MT7’s total return was +25.7%, or −1.4% after UK CPIH inflation. Past performance is not a guide to future returns.

Similar funds

More healthcare funds, largest first. Size is a fact, not a verdict.

Fund documents and methods

Methodology:ReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.